Search research articles
Contact Us
Filters
Showing results (31-40 of 117) with videos related to
Page
of 12
Sort By:
Vaccines
|
August 28, 2021
Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
Giovanna Cocomazzi, Valeria Piazzolla, Maria Maddalena Squillante, et al.
Recenti Progressi in Medicina
|
October 2, 2025
Francesco Giuliani, Onofrio Cappucci, Clara De Gennaro, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2010
Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates
Jean-Denis Docquier, Manuela Benvenuti, Vito Calderone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 15, 2011
Stage dependent destructuration of neuro-endocrine-immune system components in lung cancer patients
Gianluigi Mazzoccoli, Andrea Fontana, Massimiliano Copetti, et al.
American Journal of Clinical Oncology
|
December 1, 2005
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)
Francesco Giuliani, Stefano Molica, Evaristo Maiello, et al.
Cancer
|
March 29, 2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale
Giuseppe Colucci, Francesco Giuliani, Vittorio Gebbia, et al.
International Journal of Cancer
|
June 16, 2004
Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients
Angelo Paradiso, JanMing Xu, Anita Mangia, et al.
Studies in Health Technology and Informatics
|
January 25, 2024
The Role of HL7 FHIR in the European Project GATEKEEPER
Roberta Gazzarata, Catherine Chronaki, Alba Gallego, et al.
Clinical and Experimental Medicine
|
September 13, 2011
Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls
Gianluigi Mazzoccoli, Robert B Sothern, Paola Parrella, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
July 6, 2005
[Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment]
Jian-ming Xu, Bu-dong Zhu, Anita Mangia, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 117) with videos related to
Sort By:
Page
of 12
Vaccines
|
August 28, 2021
Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
Giovanna Cocomazzi, Valeria Piazzolla, Maria Maddalena Squillante, et al.
Recenti Progressi in Medicina
|
October 2, 2025
Francesco Giuliani, Onofrio Cappucci, Clara De Gennaro, et al.
Antimicrobial Agents and Chemotherapy
|
February 11, 2010
Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates
Jean-Denis Docquier, Manuela Benvenuti, Vito Calderone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 15, 2011
Stage dependent destructuration of neuro-endocrine-immune system components in lung cancer patients
Gianluigi Mazzoccoli, Andrea Fontana, Massimiliano Copetti, et al.
American Journal of Clinical Oncology
|
December 1, 2005
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)
Francesco Giuliani, Stefano Molica, Evaristo Maiello, et al.
Cancer
|
March 29, 2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale
Giuseppe Colucci, Francesco Giuliani, Vittorio Gebbia, et al.
International Journal of Cancer
|
June 16, 2004
Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients
Angelo Paradiso, JanMing Xu, Anita Mangia, et al.
Studies in Health Technology and Informatics
|
January 25, 2024
The Role of HL7 FHIR in the European Project GATEKEEPER
Roberta Gazzarata, Catherine Chronaki, Alba Gallego, et al.
Clinical and Experimental Medicine
|
September 13, 2011
Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls
Gianluigi Mazzoccoli, Robert B Sothern, Paola Parrella, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
July 6, 2005
[Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment]
Jian-ming Xu, Bu-dong Zhu, Anita Mangia, et al.
Page
of 12